Figure 5.Prognostic value of the prognostic signature in the TCGA cohort. (A) the risk score and (B) the survival status of LUAD patients, (C) Kaplan-Meier survival analysis, (D) ROC analysis.
Figure 5 — A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients | Aging
